Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Methicillin-resistant S. Aureus
100%
Phage
100%
Bacteriocin
100%
S. Aureus Infection
100%
Antibiotics
71%
Antimicrobial
57%
Staphylococcus Aureus
28%
Phage Endolysin
28%
Route of Administration
14%
Bacteriophage
14%
Clinical Trials
14%
Resistance Development
14%
Pathogenic Bacteria
14%
Trial Phase
14%
Human Health
14%
Effective Treatment
14%
Bacterial Pathogens
14%
Randomized Clinical Trial
14%
Immune Response
14%
Gastrointestinal Tract
14%
Clinical Setting
14%
Resistant Variants
14%
Eastern Europe
14%
Synergistic Effect
14%
Bioengineering
14%
Public Health
14%
Bacterial Infection
14%
Microbiome
14%
Antibiotic Resistance
14%
Food Industry
14%
Phage Therapy
14%
Nosocomial Infection
14%
Bacterial Resistance
14%
Protease-resistant
14%
Phage Treatment
14%
Antimicrobial Therapy
14%
Repurposing
14%
Local Administration
14%
Nosocomial Environment
14%
Commensal Bacteria
14%
Treatment Technology
14%
Collateral Damage
14%
Biopreservation
14%
Enzymatic Digestion
14%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Staphylococcus Aureus
100%
Meticillin
100%
Bacteriocin
100%
Bacteriophage
100%
Lantibiotic
66%
Antibiotics
44%
Infectious Agent
22%
Antibiotic Resistance
22%
Route of Administration
11%
Clinical Trial
11%
Bacterial Infection
11%
Proteinase
11%
Randomized Clinical Trial
11%
Microbiome
11%
Hospital Infection
11%
Repurposing
11%
Antimicrobial Therapy
11%
Immunology and Microbiology
Staphylococcus Aureus
100%
Bacteriophage
100%
Lantibiotic
66%
Infectious Agent
22%
Antimicrobial Resistance
22%
Endolysin
22%
Microbiome
11%
Immune Response
11%
Gastrointestinal Tract
11%